Cefaclor advanced formulation 750 mg twice daily versus clarithromycin 500 mg twice daily in the treatment of acute maxillary sinusitis (Q114948136)
Jump to navigation
Jump to search
scientific article published in 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cefaclor advanced formulation 750 mg twice daily versus clarithromycin 500 mg twice daily in the treatment of acute maxillary sinusitis |
scientific article published in 1999 |
Statements
Cefaclor advanced formulation 750 mg twice daily versus clarithromycin 500 mg twice daily in the treatment of acute maxillary sinusitis (English)
Stephen Bandak
Lynda Bolzon
Don Johns
Stacy Henle
Brad Alien
April 1999
185-194